Annual FCF
-$12.21 M
+$2.67 M+17.95%
December 31, 2023
Summary
- As of February 26, 2025, EKSO annual free cash flow is -$12.21 million, with the most recent change of +$2.67 million (+17.95%) on December 31, 2023.
- During the last 3 years, EKSO annual FCF has fallen by -$3.46 million (-39.47%).
- EKSO annual FCF is now -101658.33% below its all-time high of -$12.00 thousand, reached on March 1, 2013.
Performance
EKSO Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$2.29 M
+$385.00 K+14.42%
September 30, 2024
Summary
- As of February 26, 2025, EKSO quarterly free cash flow is -$2.29 million, with the most recent change of +$385.00 thousand (+14.42%) on September 30, 2024.
- Over the past year, EKSO quarterly FCF has stayed the same.
- EKSO quarterly FCF is now -761566.67% below its all-time high of -$300.00, reached on March 31, 2013.
Performance
EKSO Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$10.06 M
+$1.08 M+9.74%
September 30, 2024
Summary
- As of February 26, 2025, EKSO TTM free cash flow is -$10.06 million, with the most recent change of +$1.08 million (+9.74%) on September 30, 2024.
- Over the past year, EKSO TTM FCF has stayed the same.
- EKSO TTM FCF is now -116830.23% below its all-time high of -$8600.00, reached on June 30, 2012.
Performance
EKSO TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
EKSO Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +17.9% | 0.0% | 0.0% |
| 3 y3 years | -39.5% | +9.9% | -1.8% |
| 5 y5 years | +45.2% | +50.0% | +36.5% |
EKSO Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -8.9% | +17.9% | -40.4% | +46.3% | at high | +32.6% |
| 5 y | 5-year | -39.5% | +22.9% | -79.9% | +46.3% | -18.2% | +36.5% |
| alltime | all time | <-9999.0% | +61.5% | <-9999.0% | +76.5% | <-9999.0% | +68.3% |
Ekso Bionics Holdings Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$2.29 M(-14.4%) | -$10.06 M(-9.7%) |
| Jun 2024 | - | -$2.67 M(-23.1%) | -$11.14 M(-2.5%) |
| Mar 2024 | - | -$3.47 M(+113.5%) | -$11.43 M(-6.4%) |
| Dec 2023 | -$12.21 M(-17.9%) | -$1.63 M(-51.7%) | -$12.21 M(-14.5%) |
| Sep 2023 | - | -$3.37 M(+13.9%) | -$14.28 M(+4.7%) |
| Jun 2023 | - | -$2.96 M(-30.5%) | -$13.64 M(-8.6%) |
| Mar 2023 | - | -$4.26 M(+15.1%) | -$14.93 M(+0.3%) |
| Dec 2022 | -$14.88 M(+32.7%) | -$3.70 M(+35.4%) | -$14.88 M(+4.4%) |
| Sep 2022 | - | -$2.73 M(-35.7%) | -$14.26 M(+1.4%) |
| Jun 2022 | - | -$4.25 M(+1.0%) | -$14.06 M(+4.8%) |
| Mar 2022 | - | -$4.21 M(+36.8%) | -$13.42 M(+19.7%) |
| Dec 2021 | -$11.21 M(+28.1%) | -$3.07 M(+21.3%) | -$11.21 M(+13.5%) |
| Sep 2021 | - | -$2.54 M(-29.7%) | -$9.88 M(+14.7%) |
| Jun 2021 | - | -$3.61 M(+80.3%) | -$8.62 M(-4.6%) |
| Mar 2021 | - | -$2.00 M(+14.9%) | -$9.03 M(+3.2%) |
| Dec 2020 | -$8.76 M(-44.7%) | -$1.74 M(+37.0%) | -$8.76 M(+2.9%) |
| Sep 2020 | - | -$1.27 M(-68.4%) | -$8.51 M(-27.9%) |
| Jun 2020 | - | -$4.02 M(+133.6%) | -$11.81 M(-4.5%) |
| Mar 2020 | - | -$1.72 M(+15.2%) | -$12.37 M(-21.9%) |
| Dec 2019 | -$15.83 M(-29.0%) | -$1.50 M(-67.3%) | -$15.83 M(-19.1%) |
| Sep 2019 | - | -$4.57 M(-0.3%) | -$19.57 M(+1.8%) |
| Jun 2019 | - | -$4.58 M(-11.6%) | -$19.23 M(-7.1%) |
| Mar 2019 | - | -$5.18 M(-1.0%) | -$20.70 M(-7.1%) |
| Dec 2018 | -$22.30 M | -$5.23 M(+23.8%) | -$22.30 M(-2.2%) |
| Sep 2018 | - | -$4.23 M(-30.2%) | -$22.81 M(-16.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2018 | - | -$6.06 M(-10.6%) | -$27.41 M(-11.8%) |
| Mar 2018 | - | -$6.78 M(+17.9%) | -$31.07 M(-1.9%) |
| Dec 2017 | -$31.68 M(+21.4%) | -$5.75 M(-34.9%) | -$31.68 M(+3.0%) |
| Sep 2017 | - | -$8.83 M(-9.1%) | -$30.75 M(+7.9%) |
| Jun 2017 | - | -$9.71 M(+31.4%) | -$28.48 M(+7.8%) |
| Mar 2017 | - | -$7.39 M(+53.7%) | -$26.41 M(+1.2%) |
| Dec 2016 | -$26.09 M(+32.0%) | -$4.81 M(-26.7%) | -$26.09 M(-3.4%) |
| Sep 2016 | - | -$6.56 M(-14.1%) | -$27.00 M(+6.1%) |
| Jun 2016 | - | -$7.64 M(+8.1%) | -$25.46 M(+12.0%) |
| Mar 2016 | - | -$7.07 M(+23.7%) | -$22.73 M(+15.0%) |
| Dec 2015 | -$19.76 M(+19.8%) | -$5.72 M(+13.8%) | -$19.76 M(+14.1%) |
| Sep 2015 | - | -$5.02 M(+2.3%) | -$17.33 M(+7.4%) |
| Jun 2015 | - | -$4.91 M(+19.5%) | -$16.13 M(+9.1%) |
| Mar 2015 | - | -$4.11 M(+25.2%) | -$14.79 M(-10.3%) |
| Dec 2014 | -$16.49 M(>+9900.0%) | -$3.28 M(-14.3%) | -$16.49 M(+24.8%) |
| Sep 2014 | - | -$3.83 M(+7.2%) | -$13.21 M(+40.8%) |
| Jun 2014 | - | -$3.57 M(-38.5%) | -$9.39 M(+60.7%) |
| Mar 2014 | - | -$5.81 M(>+9900.0%) | -$5.84 M(>+9900.0%) |
| Dec 2013 | - | -$1900.00(+26.7%) | -$30.90 K(+0.3%) |
| Sep 2013 | - | -$1500.00(-94.5%) | -$30.80 K(+0.7%) |
| Jun 2013 | - | -$27.20 K(+8966.7%) | -$30.60 K(+155.0%) |
| Mar 2013 | - | -$300.00(-83.3%) | -$12.00 K(+2.6%) |
| Mar 2013 | -$12.00 K | - | - |
| Dec 2012 | - | -$1800.00(+38.5%) | -$11.70 K(+18.2%) |
| Sep 2012 | - | -$1300.00(-84.9%) | -$9900.00(+15.1%) |
| Jun 2012 | - | -$8600.00 | -$8600.00 |
FAQ
- What is Ekso Bionics Holdings annual free cash flow?
- What is the all time high annual FCF for Ekso Bionics Holdings?
- What is Ekso Bionics Holdings annual FCF year-on-year change?
- What is Ekso Bionics Holdings quarterly free cash flow?
- What is the all time high quarterly FCF for Ekso Bionics Holdings?
- What is Ekso Bionics Holdings quarterly FCF year-on-year change?
- What is Ekso Bionics Holdings TTM free cash flow?
- What is the all time high TTM FCF for Ekso Bionics Holdings?
- What is Ekso Bionics Holdings TTM FCF year-on-year change?
What is Ekso Bionics Holdings annual free cash flow?
The current annual FCF of EKSO is -$12.21 M
What is the all time high annual FCF for Ekso Bionics Holdings?
Ekso Bionics Holdings all-time high annual free cash flow is -$12.00 K
What is Ekso Bionics Holdings annual FCF year-on-year change?
Over the past year, EKSO annual free cash flow has changed by +$2.67 M (+17.95%)
What is Ekso Bionics Holdings quarterly free cash flow?
The current quarterly FCF of EKSO is -$2.29 M
What is the all time high quarterly FCF for Ekso Bionics Holdings?
Ekso Bionics Holdings all-time high quarterly free cash flow is -$300.00
What is Ekso Bionics Holdings quarterly FCF year-on-year change?
Over the past year, EKSO quarterly free cash flow has changed by $0.00 (0.00%)
What is Ekso Bionics Holdings TTM free cash flow?
The current TTM FCF of EKSO is -$10.06 M
What is the all time high TTM FCF for Ekso Bionics Holdings?
Ekso Bionics Holdings all-time high TTM free cash flow is -$8600.00
What is Ekso Bionics Holdings TTM FCF year-on-year change?
Over the past year, EKSO TTM free cash flow has changed by $0.00 (0.00%)